Impact of donor age on cardiac transplantation outcomes and on cardiac function

Themistokles Chamogeorgakis1, Susie Joseph2, Shelley Hall2

  • 1Department of Thoracic and Cardiac Surgery, Baylor University Medical Center at Dallas, Dallas, TX, USA themistokles.chamogeorgakis@baylorhealth.edu.

Insights

Using hearts from donors over 50 years old for heart transplantation does not negatively impact survival or graft function. Careful donor selection ensures comparable outcomes, allowing expanded use of older donor hearts.

Area of Science:

  • Cardiology
  • Transplant Surgery
  • Geriatric Medicine

Background:

  • Conflicting data exists regarding the impact of older donor age on heart transplant outcomes.
  • Previous studies have not definitively established survival results for older donor heart transplants.

Purpose of the Study:

  • To analyze the impact of older donor age on heart transplant survival and myocardial function.
  • To compare transplant outcomes between younger and older donor groups.

Main Methods:

  • Retrospective review of heart transplant recipients at Baylor University Medical Center (Nov 2012-Mar 2015).
  • Division of recipients into two groups based on donor age (≥50 years vs. <50 years).
  • Comparison of in-hospital/1-year survival, rejection, graft dysfunction, inotropic score, ejection fraction, and length of stay.

Main Results:

  • No significant difference in in-hospital or 1-year survival between older and younger donor groups.
  • Older donors had a higher incidence of death due to intracranial bleeding (48.1%) versus anoxia (43.9%) in younger donors.
  • No increased risk of graft dysfunction, higher inotropic support, longer hospital stays, or severe rejection episodes with older donors.

Conclusions:

  • Heart transplantation from carefully selected donors over 50 years old is not associated with reduced survival or impaired graft function.
  • The use of hearts from donors >50 years can be safely expanded to carefully selected recipients, not just critically ill ones.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
666
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.2K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
310
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
310
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
324